Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

306 results found

2016 ∙ Kraicer-Melamed, H. O'Donnell, S. Quach, C.

The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Voysey, M. Sadarangani, M. Clutterbuck, E. Bolgiano, B. Pollard, A. J.

The impact of administration of conjugate vaccines containing cross reacting material on Haemophilus influenzae type b antibody responses in infants: A systematic review and meta-analysis of randomised controlled trials

  • Newborn
  • Haemophilus influenzae type B
  • Meningococcal disease
  • Pneumococcal disease
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Nicholls, T. R. Leach, A. J. Morris, P. S.

The short-term impact of each primary dose of pneumococcal conjugate vaccine on nasopharyngeal carriage: Systematic review and meta-analyses of randomised controlled trials

  • Newborn
  • Influenza
  • Pneumococcal disease
  • Streptococcus group B
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Health Council of the Netherlands

11th meeting of the Committee on Vaccination

  • Agenda & Minutes
  • Europe
  • Netherlands
  • Pneumococcal disease
Download:
2016 ∙ Ole Wichmann, E Hummers-Pradier, T Ledig, STIKO, Cornelius Remschmidt, Thomas Harder, G Falkenhorst, S Glodny, Christian Bogdan

Background paper to the updated pneumococcal vaccination recommendation for older adults in Germany

  • Background paper
  • Europe
  • Germany
  • Pneumococcal disease
Download:
2016 ∙ CoPI

Recommendation on the Replacement of PCV-10 with PCV-13

  • Recommendation
  • Africa
  • Mozambique
  • Pneumococcal disease
Download:
2015 ∙ Malerba, V. Costantino, C. Napoli, G. Marchese, V. Casuccio, A. Tabacchi, G. Vitale, F.

Antimeningococcal and antipneumococcal vaccination determinants: a European systematic literature review

  • Europe
  • Adolescents
  • Adults
  • Older adults
  • Parents/caregivers
  • Meningococcal disease
  • Pneumococcal disease
  • Coverage
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2015 ∙ Vlachopoulos, C. V. Terentes-Printzios, D. G. Aznaouridis, K. A. Pietri, P. G. Stefanadis, C. I.

Association between pneumococcal vaccination and cardiovascular outcomes: A systematic review and meta-analysis of cohort studies

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2015 ∙ Wu, D. B. C. Chaiyakunapruk, N. Chong, H. Y. Beutels, P.

Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: A review of economic evaluations (2006-2014)

  • All age groups
  • Pneumococcal disease
  • Economic aspects
  • Administration
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2015 ∙ Caya, C. A. Boikos, C. Desai, S. Quach, C.

Dosing regimen of the 23-valent pneumococcal vaccination: A systematic review

  • All age groups
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
Loading...